Data as of Dec 24
| +0.99 / +1.84%|
The 14 analysts offering 12-month price forecasts for DexCom Inc have a median target of 54.50, with a high estimate of 65.00 and a low estimate of 28.50. The median estimate represents a -0.80% decrease from the last price of 54.94.
The current consensus among 15 polled investment analysts is to Buy stock in DexCom Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.